3D model is for representation purpose only.
.
.
SSFY | Cyclophosphamide |
Identification | |
---|---|
ConjuPepDB ID | cpd01034 |
Smiles | |
Molecular weight | 893.268 |
Molecular formula | C39H50Cl2N7O11P |
Chemical name | Peptide information |
Sequence (one letter) | SSFY |
Length | 4 |
Peptide name | tetrapeptide |
External ID | |
---|---|
CAS number | 1161754-69-3 |
Other information | |
---|---|
Application | Anticancer therapy, prostate cancer |
Additional function | targeting prostate cancer (prodrug) |
Pharmacological class | anticancer |
Conjugate type | amide |
Linker | no |
Small molecule | Cyclophosphamide |
Small molecule CAS | 50-18-0 |
Small molecule structure | |
Structure method | 1H and 31P NMR |
Calculated properties | |
---|---|
LogP | 0.76759 |
Rotatable bonds | 23 |
H bond donor | 9 |
H bond acceptor | 9 |
Polar surface area (PSA) | 256.99000 |
Citations | |||||
---|---|---|---|---|---|
ID | Title | Year | Authors | Journal | DOI |
Synthesis and stereochemical preference of peptide 4-aminocyclophosphamide conjugates as potential prodrugs of phosphoramide mustard for activation by prostate-specific antigen (PSA) | 2009 | Jiang, Yongying; Di Paola, Robert S.; Hu, Longqin | Bioorganic & Medicinal Chemistry |